(Thermal) Quantitative Sensory Testing—tQST  by Di Pietro, Flavia & McAuley, James H.
Journal of Physiotherapy 2011  Vol. 57  –   © Australian Physiotherapy Association 201158
Appraisal Clinimetrics
(Thermal) Quantitative Sensory Testing—tQST
Description
Quantitative sensory testing (QST) is a collection of 
individual tests designed to assess the somatosensory 
system, particularly of patients with neuropathic pain or 
suspected neurologic disease (Rolke et al 2006b, Shy et 
al 2003). Pressure algometry, one of the individual QST 
tests, has previously been discussed in Clinimetrics (Ylinen 
2007); this article focuses on the thermal component of the 
QST protocol (tQST), which requires the use of a Thermal 
Sensory Analysera (TSA) or an Modular Sensory Analyserb 
(MSA) (Rolke et al 2006a).
The tQST protocol is used to detect cold and warm 
thresholds, paradoxical heat sensations, and cold and heat 
pain thresholds (Rolke et al 2006a, Rolke et al 2006b). The 
most common method for threshold determination is the 
‘method of limits’. This involves the patient indicating as 
soon as he or she detects either a hot or cold stimulus as 
the strength of the signal gradually increases. Alternatively, 
depending on the particular test, the patient may indicate 
when the stimulus is no longer detected as its strength is 
gradually decreased (Rolke et al 2006a, Shy et al 2003).
Clinimetrics: The tQST protocol described by Rolke and 
colleagues comprises a series of tests primarily intended 
to assist with the diagnosis of pain mechanisms, for 
example central sensitisation (Rolke et al 2006b). Although 
the individual component tests of the protocol have been 
previously validated, further studies are needed to evaluate 
the validity of the complete QST battery (Rolke et al 
2006b). There is also a lack of data on the validity of the 
tQST protocol to diagnose speciﬁc neurological conditions, 
the absence of which has probably limited the acceptance 
of tQST in the clinical management of painful conditions 
(Backonja et al 2009, Shy et al 2003).
tQST has been found to demonstrate good reproducibility, 
performed with the method of limits at different test 
intervals (Heldestad et al 2010). For example coefﬁcients 
of repeatability (the minimal detectable change between 
measurements, expressed in C°) between testing on Days 
1, 2, and 7 ranged from 0.62 to 1.35 for both warm and 
cold thresholds. However, as values ranged from 1.64 to 
3.14 when heat and cold pain thresholds preceded threshold 
testing, Heldestad et al (2010) have stressed the importance 
of conducting thermal threshold testing prior to pain 
thresholds so that reproducibility is optimised. Signiﬁcant 
correlations in tQST results have been found over two days 
in a sample of chronic pain sufferers and healthy subjects 
(range r = 0.41 to 0.62) (Agostinho et al 2009).
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Commentary
tQST is best suited to quantifying positive sensory 
phenomena, such as allodynia and hyperalgesia; it is 
most suitable as a within-patient outcome measure of 
pharmacological and non-pharmacological treatment effect 
on somatosensory function in those with neuropathic pain 
(Backonja et al 2009, Cruccu et al 2010, Rolke et al 2006a).
QST normative values have been published and serve as a 
reference against which patients’ results can be evaluated 
(Rolke et al 2006a). However, as many variables can affect 
the results of an assessment comparing scores from different 
subjects, examiners, settings or, perhaps most signiﬁcantly, 
testing apparatus, can be difﬁcult (Shy et al 2003).
As with any psychophysical test (ie, a test requiring co-
operation from the patient) care must be taken in the 
interpretation of results. This is particularly relevant with 
the interpretation of tQST scores since the tests rely heavily 
on patient perceptions and responses (Backonja et al 2009, 
Shy et al 2003). In order to optimise the reliability of the 
measure, there is a critical need for standardised physical 
properties of the stimulus, closely standardised instruction, 
and investigator training (Backonja et al 2009).
The lack of evidence-based diagnostic criteria for tQST for 
neurological conditions is a likely explanation of why tQST 
is more common in the neuroscience research setting than 
in clinics. Practical considerations and cost are likely to also 
play a signiﬁcant role (the tQST assessment takes around 45 
minutes to set up, perform, and record, and tQST units can 
cost around AU$40 000). However the study of neuropathic 
pain is a rapidly developing area of clinical research in 
which tQST is likely to play an increasingly signiﬁcant role. 
With appropriate application and interpretation the tool 
will likely be utilised more in clinical practice (Backonja 
et al 2009). tQST robustness will ultimately depend on 
investigator training and method, and its results are likely 
best interpreted in light of the broader clinical picture.
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